Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00559039|
Recruitment Status : Completed
First Posted : November 16, 2007
Last Update Posted : March 8, 2012
RATIONALE: Gathering information about pregnancy, infancy, and early childhood exposures may help doctors identify cancer risk factors, and may help the study of cancer.
PURPOSE: This natural history study is looking at the effects of fetal, infant, and early childhood exposures on adult cancer risk in women.
|Condition or disease||Intervention/treatment|
|Breast Cancer Unspecified Adult Solid Tumor, Protocol Specific||Other: questionnaire administration Procedure: evaluation of cancer risk factors|
- Determine if fetal, infant, and early childhood exposures are associated with adult cancer risk in women.
OUTLINE: Mothers of nurses complete questionnaires to collect maternal data, such as pregnancy weight gain, diet during pregnancy, maternal pre-eclampsia, gestational diabetes, gestational age at birth, birth weight, and infant feeding practices. Maternal data is linked to other data collected from critical time periods in the nurses's life cycle, such as menarche, first pregnancy, or adult dietary intake.
|Study Type :||Observational|
|Estimated Enrollment :||128700 participants|
|Official Title:||Fetal, Infant and Early Childhood Antecedents of Cancer in Women: Maternal Cohort Study of the Nurses' Health Studies|
|Study Start Date :||October 2000|
|Actual Study Completion Date :||October 2006|
- Diagnosis of incident cancers and other chronic diseases
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00559039
|United States, Maryland|
|Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office|
|Bethesda, Maryland, United States, 20892-1182|
|Principal Investigator:||Michele R. Forman, PhD||M.D. Anderson Cancer Center|